Our modeling and simulation services offer advanced techniques such as PBPK (Physiologically Based Pharmacokinetic) modeling, First-In-Human (FIH) predictions, and quality-by-design assessments. These models enable us to predict your drug’s behavior in the human body, optimize clinical trial design, and assess the impact of formulation changes early in development. We also provide in-vitro/in-vivo correlations and bioequivalence assessments, allowing for data-driven decisions that support regulatory submissions and ensure product performance throughout development.